The Lefèvre retentive cup compared with the dual mobility cup in total hip arthroplasty revision for dislocation.


Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 03 2020
accepted: 27 04 2020
pubmed: 10 5 2020
medline: 15 4 2021
entrez: 10 5 2020
Statut: ppublish

Résumé

Limiting the risk of dislocation is one of the main aims of both dual mobility and Lefèvre retentive cups. However, these devices have never been compared. The goal of our study was to compare these devices in total hip arthroplasty revisions for instability. The judgement criterion was non-recurrence of dislocation in a follow-up period of eight years. This retrospective case-control study compared two continuous paired series of total hip arthroplasty revisions for instability. These series included 63 patients and 159 patients with implantation of a Lefèvre retentive cup and a dual mobility cup, respectively. The success rate at eight years (i.e., no recurrence) was 91 ± 0.05% and 95 ± 0.02% in the Lefèvre retentive cup and dual mobility groups, respectively. The difference was not statistically significant (p = 0.6). It seems that the Lefèvre retentive cup provides comparable outcomes with the dual mobility cup in the total hip arthroplasty revisions for instability, avoiding recurrence in long term.

Sections du résumé

BACKGROUND
Limiting the risk of dislocation is one of the main aims of both dual mobility and Lefèvre retentive cups. However, these devices have never been compared. The goal of our study was to compare these devices in total hip arthroplasty revisions for instability. The judgement criterion was non-recurrence of dislocation in a follow-up period of eight years.
METHODS
This retrospective case-control study compared two continuous paired series of total hip arthroplasty revisions for instability. These series included 63 patients and 159 patients with implantation of a Lefèvre retentive cup and a dual mobility cup, respectively.
RESULTS
The success rate at eight years (i.e., no recurrence) was 91 ± 0.05% and 95 ± 0.02% in the Lefèvre retentive cup and dual mobility groups, respectively. The difference was not statistically significant (p = 0.6).
CONCLUSION
It seems that the Lefèvre retentive cup provides comparable outcomes with the dual mobility cup in the total hip arthroplasty revisions for instability, avoiding recurrence in long term.

Identifiants

pubmed: 32385555
doi: 10.1007/s00264-020-04601-1
pii: 10.1007/s00264-020-04601-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1661-1667

Auteurs

Julien Labban (J)

Department of Orthopaedic and Traumatology Surgery, Brest University Hospital, Brest, France. dr.julien.labban@gmail.com.
School of Medicine, Western Brittany University, Brest, France. dr.julien.labban@gmail.com.

Hoël Letissier (H)

Department of Orthopaedic and Traumatology Surgery, Brest University Hospital, Brest, France.
School of Medicine, Western Brittany University, Brest, France.

Patrice Mertl (P)

Department of Orthopaedic Surgery, Amiens University Hospital, Amiens, France.

Christian Lefèvre (C)

Department of Orthopaedic and Traumatology Surgery, Brest University Hospital, Brest, France.
School of Medicine, Western Brittany University, Brest, France.
Laboratoire d'Analyse et de Traitement de l'Information Médicale, LaTIM UMR 1101 Institut National de la Santé Et de la Recherche Médicale, Université de Bretagne Occidentale INSERM-UBO, Brest, France.

Henri Migaud (H)

Department of Orthopaedic Surgery, Lille University Hospital, Lille, France.

Arnaud Clavé (A)

Laboratoire d'Analyse et de Traitement de l'Information Médicale, LaTIM UMR 1101 Institut National de la Santé Et de la Recherche Médicale, Université de Bretagne Occidentale INSERM-UBO, Brest, France.
Department of Orthopaedic Surgery, Saint-George Private Hospital, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH